Atazanavir
Atazanavir (Latazanavir, Zrivada, Reyataz, BMS-232632) is an azapeptide and HIV-protease inhibitor that is used in the treatment of HIV infections and AIDS in combination with other anti-HIV agents. Atazanavir is a substrate and inhibitor of cytochrome P450 isozyme 3A (CYP3A4) and an inhibitor and inducer of P-glycoprotein.
| Trivial name | Latazanavir, Zrivada, Reyataz, BMS-232632 |
| Catalog Number | S4662 |
| Molecular Formula | C15H18Br2N4.xHCl |
| CAS# | 198904-31-3 |
| Inchi | InChI=1S/C15H18Br2N4.ClH/c1-9-11(16)12(17)10-3-2-6-21-14(10)13(9)19-15(21)20-7-4-18-5-8-20;/h18H,2-8H2,1H3;1H |
| Inchi Key | GQXLWUCQESKBSC-UHFFFAOYSA-N |
| SMILES | CC1=C2C3=C(CCCN3C(=N2)N4CCNCC4)C(=C1Br)Br |
| Size | 50mg |
| Supplier Page | http://www.selleckchem.com/products/atazanavir-reyataz.html |
| Additional Information | https://file.selleck.cn/downloads/struct/atazanavir-chemical-structure-s4662.gif |